NMPA-2021-0004-V204

Type IB variation for application NMPA-2021-0004. Type IB variation: Formulation Change for Semaglutidex — minor update

Variation Number
NMPA-2021-0004-V204
Type
Type IB
Application
NMPA-2021-0004
Change
CHG-2021-0204
Status
Active
Fee
€3,815
Submitted
—
Approved
—
Description

Type IB variation: Formulation Change for Semaglutidex — minor update